Skip to content Accessibility tools

DOH: Tuesday, October 26 – CDC COCA Call – What Clinicians Need to Know about the Recent Updates to the CDC’s Recommendations for COVID-19 Boosters

The Centers for Disease Control and Prevention (CDC) is hosting a Clinician Outreach and Communication Activity (COCA) Call on Tuesday, October 26, 2021 from 2:00 PM to 3:00 PM EST regarding recent updates to the CDC’s recommendations for COVID-19 vaccine booster doses. Registration is not required. Information regarding this COCA Cal is included below.

What Clinicians Need to Know about the Recent Updates to CDC’s Recommendations for COVID-19 Boosters

This COCA call will provide an overview of the most recent recommendations for administering COVID-19 booster vaccines. The Centers for Disease Control and Prevention will provide updates about the latest recommendations and clinical considerations for administering COVID-19 boosters, including an update on early safety monitoring for additional COVID-19 vaccine doses.

If you are unable to attend the live COCA Call, the recording will be available for viewing on the COCA Call webpage a few hours after the live event ends.

The slide set will be available under Call Materials on the COCA Call webpage.

Continuing Education will not be offered for this COCA Call.

Registration is not required.

Date: Tuesday, October 26, 2021

Time: 2:00 pm – 3:00 pm (ET)

A few minutes before the webinar starts, please click on the Zoom link below to join: https://www.zoomgov.com/j/1603968267

Or One tap mobile: 

US:+16692545252,,1603968267#,,,,*581643# or +16468287666,,1603968267#,,,,*581643#

Or Telephone:

US: +1 669 254 5252 or +1 646 828 7666

or +1 669 216 1590 or +1 551 285 1373

Webinar ID: 160 396 8267

Passcode: 581643

 

International numbers available:

https://www.zoomgov.com/u/ab2UFvSsCsOCA Call Objectives

At the conclusion of the session, the participant will be able to accomplish the following

  1. Cite background information on the topic covered during the presentation.
  2. Discuss CDC’s role in the topic covered during the presentation.
  3. Describe the topic’s implications for clinicians.
  4. Discuss concerns and/or issues related to preparedness for and/or response to urgent public health threats.
  5. Promote health improvement, wellness, and disease prevention in cooperation with patients, communities, at-risk populations, and other members of an interprofessional team of healthcare providers.

Anne Hause, PhD
Vaccine Task Force
COVID-19 Response
Centers for Disease Control and Prevention

Kathleen Dooling, MD, MPH
Vaccine Task Force
COVID-19 Response
Centers for Disease Control and Prevention 

Sujan Reddy, MD, MSc
Vaccine Task Force
COVID-19 Response
Centers for Disease Control and Prevention

The Emergency Risk Communication Branch in the Division of Emergency Operations, Center for Preparedness and Response is responsible for the management of all COCA products.

For information about this update or other clinical issues, or to send your feedback, please contact us at coca@cdc.gov

CDC and HHS logos are the exclusive property of the Department of Health and Human Services and may not be used for any purpose without prior express written permission. Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of Health and Human Services.

Links to non-federal organizations are provided solely as a service to our users. Links do not constitute an endorsement of any organization by CDC or the federal government, and none should be inferred. CDC is not responsible for the content of the individual organizations.

NYSHFA/NYSCAL CONTACTS:

Lisa Volk, RN, B.P.S., LNHA
Director, Clinical & Quality Services
518-462-4800 x15